{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:21:39Z","timestamp":1793816499724,"version":"4.6.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00464-023-10389-z","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T16:02:01Z","timestamp":1694016121000},"page":"8285-8290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Transoral gastric outlet reduction for post-prandial hypoglycemia after Roux-en-Y gastric bypass"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1878-7916","authenticated-orcid":false,"given":"Samuel Hunter","family":"Dunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaa","family":"Tejani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime P.","family":"Almandoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Messiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Schellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa Morales","family":"Marroquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tavakkoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"key":"10389_CR1","doi-asserted-by":"publisher","first-page":"946870","DOI":"10.3389\/fendo.2022.946870","volume":"13","author":"DM Abboud","year":"2022","unstructured":"Abboud DM, Yao R, Rapaka B et al (2022) Endoscopic management of weight recurrence following bariatric surgery. Front Endocrinol 13:946870","journal-title":"Front Endocrinol"},{"key":"10389_CR2","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.soard.2016.04.017","volume":"12","author":"JB Nielsen","year":"2016","unstructured":"Nielsen JB, Pedersen AM, Gribsholt SB et al (2016) Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypass. Surg Obes Relat Dis 12:1562\u20131568","journal-title":"Surg Obes Relat Dis"},{"key":"10389_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.soard.2016.12.005","volume":"13","author":"D Eisenberg","year":"2017","unstructured":"Eisenberg D, Azagury DE, Ghiassi S et al (2017) ASMBS position statement on postprandial hyperinsulinemic hypoglycemia after bariatric surgery. Surg Obes Relat Dis 13:371\u2013378","journal-title":"Surg Obes Relat Dis"},{"key":"10389_CR4","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41574-020-0357-5","volume":"16","author":"E Scarpellini","year":"2020","unstructured":"Scarpellini E, Arts J, Karamanolis G et al (2020) International consensus on the diagnosis and management of dumping syndrome. Nat Rev Endocrinol 16:448\u2013466","journal-title":"Nat Rev Endocrinol"},{"key":"10389_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2147\/DMSO.S123244","volume":"9","author":"FA Cadegiani","year":"2016","unstructured":"Cadegiani FA, Silva OS (2016) Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients. Diabetes Metab Syndr Obes Targets Ther 9:443\u2013446","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"10389_CR6","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/j.1365-2036.2005.02681.x","volume":"22","author":"C Penning","year":"2005","unstructured":"Penning C, Vecht J, Masclee AAM (2005) Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome. Aliment Pharm Ther 22:963\u2013969","journal-title":"Aliment Pharm Ther"},{"key":"10389_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molmet.2017.12.011","volume":"9","author":"DB Davis","year":"2018","unstructured":"Davis DB, Khoraki J, Ziemelis M et al (2018) Roux en Y gastric bypass hypoglycemia resolves with gastric feeding or reversal: confirming a non-pancreatic etiology. Mol Metab 9:15\u201327","journal-title":"Mol Metab"},{"key":"10389_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.gie.2020.02.029","volume":"92","author":"EJ Vargas","year":"2020","unstructured":"Vargas EJ, Dayyeh BKA, Storm AC et al (2020) Endoscopic management of dumping syndrome after Roux-en-Y gastric bypass: a large international series and proposed management strategy. Gastrointest Endosc 92:91\u201396","journal-title":"Gastrointest Endosc"},{"key":"10389_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.soard.2009.04.002","volume":"6","author":"G Fern\u00e1ndez-Esparrach","year":"2010","unstructured":"Fern\u00e1ndez-Esparrach G, Lautz DB, Thompson CC (2010) Peroral endoscopic anastomotic reduction improves intractable dumping syndrome in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis 6:36\u201340","journal-title":"Surg Obes Relat Dis"},{"key":"10389_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cgh.2010.11.004","volume":"9","author":"BKA Dayyeh","year":"2011","unstructured":"Dayyeh BKA, Lautz DB, Thompson CC (2011) Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass. Clin Gastroenterol Hepatol 9:228\u2013233","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10389_CR11","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1007\/s00464-019-07137-7","volume":"34","author":"C Tsai","year":"2020","unstructured":"Tsai C, Steffen R, Kessler U et al (2020) Short-term outcomes of endoscopic gastro-jejunal revisions for treatment of dumping syndrome after Roux-en-Y gastric bypass. Surg Endosc 34:3626\u20133632","journal-title":"Surg Endosc"},{"key":"10389_CR12","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1007\/s11695-016-2266-1","volume":"26","author":"C Stier","year":"2016","unstructured":"Stier C, Chiappetta S (2016) Endoluminal revision (OverStitch TM, Apollo Endosurgery) of the dilated gastroenterostomy in patients with late dumping syndrome after proximal Roux-en-Y gastric bypass. Obes Surg 26:1978\u20131984","journal-title":"Obes Surg"},{"key":"10389_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.gie.2019.11.044","volume":"91","author":"P Jirapinyo","year":"2020","unstructured":"Jirapinyo P, Kumar N, AlSamman MA et al (2020) Five-year outcomes of transoral outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass. Gastrointest Endosc 91:1067\u20131073","journal-title":"Gastrointest Endosc"},{"issue":"12","key":"10389_CR14","doi-asserted-by":"publisher","first-page":"6846","DOI":"10.1007\/s00464-020-08190-3","volume":"35","author":"R Relly","year":"2021","unstructured":"Relly R, Mati S, Aviv CN, Fishman S (2021) Endoscopic trans-oral outlet reduction after bariatric surgery is safe and effective for dumping syndrome. Surg Endosc 35(12):6846\u20136852","journal-title":"Surg Endosc"},{"issue":"11","key":"10389_CR15","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1007\/s11695-019-04113-x","volume":"29","author":"EA Conaty","year":"2019","unstructured":"Conaty EA, Novak S, Avitia R, Su B, Linn JG, Ujiki MB (2019) Endoscopic gastrojejunal revision (transoral outlet reduction) for persistent hypoglycemia after gastric bypass. Obes Surg 29(11):3773\u20133775","journal-title":"Obes Surg"},{"issue":"1","key":"10389_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/oby.23600","volume":"31","author":"DC Llewellyn","year":"2023","unstructured":"Llewellyn DC, Logan EH, Aylwin SJB et al (2023) The efficacy of GLP-1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review. Obesity 31(1):20\u201330","journal-title":"Obesity"},{"issue":"8","key":"10389_CR17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1056\/NEJMoa066254","volume":"357","author":"L Sj\u00f6str\u00f6m","year":"2007","unstructured":"Sj\u00f6str\u00f6m L, Narbro K, Sj\u00f6str\u00f6m CD et al (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357(8):741\u2013752","journal-title":"N Engl J Med"},{"issue":"12","key":"10389_CR18","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1056\/NEJMoa1700459","volume":"377","author":"TD Adams","year":"2017","unstructured":"Adams TD, Davidson LE, Litwin SE et al (2017) Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med 377(12):1143\u20131155","journal-title":"N Engl J Med"},{"issue":"1","key":"10389_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s00464-017-5671-1","volume":"32","author":"EJ Vargas","year":"2018","unstructured":"Vargas EJ, Bazerbachi F, Rizk M et al (2018) Transoral outlet reduction with full thickness endoscopic suturing for weight regain after gastric bypass: a large multicenter international experience and meta-analysis. Surg Endosc 32(1):252\u2013259","journal-title":"Surg Endosc"},{"issue":"7","key":"10389_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2337\/dc10-2415","volume":"34","author":"RR Wing","year":"2011","unstructured":"Wing RR, Lang W, Wadden TA et al (2011) Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34(7):1481\u20131486","journal-title":"Diabetes Care"},{"issue":"1","key":"10389_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.23276","volume":"51","author":"K Promrat","year":"2010","unstructured":"Promrat K, Kleiner DE, Niemeier HM et al (2010) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51(1):121\u2013129","journal-title":"Hepatology"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-023-10389-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-023-10389-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-023-10389-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T11:11:53Z","timestamp":1704712313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-023-10389-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10389"],"URL":"https:\/\/doi.org\/10.1007\/s00464-023-10389-z","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"assertion":[{"value":"4 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jaime Almandoz is a consultant for Novo Nordisk, Eli Lilli and Company, and Boehringer Ingelheim. Jay Horton is a consultant for Merck, Pfizer, and Regeneron. Samuel Dunn, Sanaa Tejani, Sarah Messiah, Jeffrey Schellinger, Elisa Marroquin, Matthew Mathew, and Anna Tavakkoli have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}